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March 21, 2006:1228–38ttenuation of inflammation induces atrial remodeling or vice
ersa.
Although this study did not include a control group, the levels
f CRP measured compare well to previously published data (1).
evels of CRP decreased after successful ablation to levels com-
arable with patients suffering from paroxysmal AF or patients in
inus rhythm at increased risk for AF. At that point, additional
harmacologic modification of the inflammatory state with an
CE inhibitor or a statin might be useful to reduce the risk of
rrhythmia recurrence (10).
Endothelial dysfunction is not influenced by ablation, restora-
ion of sinus rhythm, reverse remodeling, or a decline in inflam-
atory parameters. This finding confirms previous studies show-
ng sustained endothelial dysfunction despite a restoration of sinus
hythm by cardioversion (11), suggesting that endothelial dysfunc-
ion may not be maintained by AF.
In conclusion, we found that restoration of sinus rhythm by
blation leads to a decrease of the patient’s inflammatory state and
reverse remodeling of the left atrium.
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etters to the Editor
eft Ventricular Noncompaction,
ardiac Magnetic Resonance Imaging,
nd Neuromuscular Disorders
ith interest we read the report by Petersen et al. (1) concerning
ardiovascular magnetic resonance imaging (CMRI) in patients
ith left ventricular hypertrabeculation (LVHT), also termed
noncompaction.” Currently, several echocardiographic definitions
f LVHT exist, and up to now no CMRI-specific diagnostic
riteria for LVHT have been developed (2–4). We have, however,
oncerns and doubts as to whether the current study will clarify the
onfusion regarding the diagnosis of LVHT.
According to their definition, the investigators found by CMRI
hat “areas of non-compaction” were common in healthy volun-
eers, athletes, patients with hypertrophic or dilated cardiomyop-
thy, and aortic stenosis. Because these findings were not corre-
ated with echocardiographic or anatomic data, how can Petersen
t al. be sure that these areas were indeed “noncompacted” and not
ust the papillary muscles, false tendons, or aberrant bands, which
re common cardiac findings (5)?
When assessing the myocardial layers with different degrees of
issue compaction, how did the researchers differentiate myocar-
ium from flow artifacts? Why did they measure the ratio of
oncompacted/compacted myocardial layers in diastole and not in
ystole, as recommended by one of the echocardiographic defini-
ions (3)? How to explain the discrepancy between the relatively
mooth endocardial surface as seen on CMRI and the bizarre
orphology of trabeculations and deep intertrabecular recesses
hen examining LVHT patients echocardiographically and at
utopsy?
Echocardiography often does not visualize with clarity the left
entricular apex. Thus, we do not understand why this cardiac
egion, which can be much better visualized by CMRI than by
chocardiography, was excluded from measurements. According to
he investigators, a ratio of noncompacted to compacted myocar-
ial layers 2.3:1 in diastole distinguished “pathological” from
nonpathological” noncompaction. Why did they then diagnose
partial expression” of the disease in Patient #2, with a ratio of only
.1? What is the distinction between “nonpathological” noncom-
action and “partial expression” of noncompaction? According to
hich echocardiographic criteria was LVHT-diagnosed in the
even patients? Why were other family members of Patient #4,
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March 21, 2006:1226–38ho had a positive family history, not included? Did any of these
elatives suffer from a neuromuscular disorder? According to which
ype was LVHT transmitted in the families?
Moreover, which neuromuscular disorder was diagnosed in
atient #7? Did the patient undergo only clinical neurological
nvestigations or were invasive procedures also carried out? Were
hrombi detected in any of the investigated patients, particularly in
atient #5, who had systemic embolism?
Also, how to explain the pathomechanism of acquired LVHT,
here the myocardium was once totally compact? In these cases,
athogenetic explanations other than noncompaction of the em-
ryonic myocardium are required.
In conclusion, the distinction between “normal” and “abnormal”
rabeculation is a continuing challenge. Commonly accepted diag-
ostic criteria for LVHT should be developed based on the
orrelation of pathoanatomical and imaging findings. The diagno-
is of LVHT relies on morphological abnormalities and does not
equire a positive family history, neuromuscular disorders, embo-
ization, or regional wall motion abnormalities as additional
iagnostic criteria.
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EPLY
e thank Drs. Stöllberger and Finsterer for their interest in our
eport (1). Many of the questions they raise reflect concern with
ow we selected our study population. Their suggestion of enroll-
ng only symptomatic patients, however, with subsequent access to
athoanatomical specimens in order to establish diagnostic criteria
ould heavily bias findings to the severe end of the spectrum.
Concerns raised by Drs. Stöllberger and Finsterer do not
ecognize that the likelihood of any individual with a ratio of
hicknesses between the trabecular and compact myocardium
2.3:1 suffering from pathological noncompaction, when ex- cressed as the posterior probability, depends on the pretest
robability or prevalence. A patient with a known family history of
oncompaction and a 1 in 2 chance of having inherited the
ondition in autosomal dominant fashion would have a 97%
hance of suffering from pathological noncompaction. In contrast,
iven the estimated prevalence of significant noncompaction of 1
n every 2,000 members of the normal population (2), the posterior
robability would only be 26%. This Bayesian calculation (3)
xemplifies the importance of taking into account the pretest
robability, especially in diseases with relatively low prevalence.
We included one patient with left ventricular noncompaction
n the basis of marked electrocardiographic changes, a family
istory of left ventricular noncompaction, and a distinct bilaminar
ppearance of the trabeculated and compacted layers of the
yocardium. Based on imaging findings alone, this patient would
ot have been diagnosed with left ventricular noncompaction.
nterestingly, this patient very recently developed symptomatic
ardiac failure. This patient, now with clinical evidence of disease,
ut in the face of an initially nondiagnostic ratio between the
rabecular and compacted layers, must now be assumed partially to
xpress the disease, whereas a healthy volunteer with a low pretest
robability would be interpreted as having nonpathological non-
ompaction.
We agree that the pathophysiological mechanisms leading to
eft ventricular noncompaction are not fully understood. Our data
n the segmental distribution of trabeculated myocardium, none-
heless, support the hypothesis of an early arrest during the
mbryological process of compaction.
Our experience is that trabeculations can be more readily
isualized in the relaxed heart. Magnetic resonance imaging (MRI)
llows easy delineation of the epicardial border in both systole and
iastole, in contrast to echocardiography, with poor epicardial
elineation in diastole. State-of-the-art sequences, such as steady-
tate free precession, are not prone to flow artifacts, as once seen
ith the older sequences employing gradient echo techniques. The
ew sequences permit clear distinction between the trabeculations
nd the compacted myocardium. This makes this imaging tech-
ique ideal to distinguish noncompaction from papillary muscles,
alse tendons, and aberrant bands, because it has the accuracy to
ermit analysis of the entirety of the ventricular mass. We are
urprised that Drs. Stöllberger and Finsterer raise this point as it is
idely acknowledged that MRI, unlike echocardiography, does
ot suffer from this caveat.
Because of the constraints of space, we can only answer some of
he further enquiries concerning the patients studied. An apical
hrombus was detected by contrast-enhanced MRI in the patient
ith a history of systemic embolism. We enrolled all first-degree
embers of our families with left ventricular noncompaction who
greed to participate in the study and to undergo screening. None
f our patients, including the seventh patient, had a family history
f neuromuscular disorders. Our patients with left ventricular
oncompaction and a positive family history showed an autosomal
ominant pattern of transmission.
In conclusion, our study demonstrated the high diagnostic
ccuracy of cardiovascular MRI for left ventricular noncompaction.
wing to the importance of pretest probabilities, we disagree with
he view that the diagnosis of left ventricular noncompaction
hould rely exclusively on morphological abnormalities. Thus,
ssessments using either echocardiography or cardiovascular MRI
an at best contribute to the clinical diagnosis.
